Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Portuguese companies are offering health technology expertise to support the transformation of Saudi Arabia's healthcare system under Vision 2030.Sub-event
- Vision 2030 integrates health goals with national development, driven by the Health Sector Transformation Program.Sub-event
Market growth in healthcare is linked to Vision 2030 initiatives in Saudi Arabia.1 source
Keep exploring
Part of
Vision 2030 is driving government initiatives in Saudi Arabia, leading to market growth contributions from various companies including Ecolab, Dow, Calgon Carbon, Pentair, DuPont, and others.Also in this story
- Pegasystems deployed Pega Cloud on Google Cloud in Saudi Arabia to support local data residency goals.
- KAEC aims to be a lifestyle-led investment destination as part of the broader Vision 2030 initiatives in Saudi Arabia.
- INTT executes its VISION 2030 Growth Strategy, with Nick Grant serving as President and CEO.
- Expro delivered its first fully remote cementing operation and is expanding its operations into the Middle East market.
The entities involved
-
Vision 2030
Slovak company
-
Saudi Arabia
country in West Asia
-
Bio-Rad Laboratories
American life science research firm
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireSaudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific